4G9S image
Deposition Date 2012-07-24
Release Date 2012-11-07
Last Version Date 2023-09-13
Entry Detail
PDB ID:
4G9S
Title:
Crystal structure of Escherichia coli PliG in complex with Atlantic salmon g-type lysozyme
Biological Source:
Source Organism:
Salmo salar (Taxon ID: 8030)
Escherichia coli (Taxon ID: 562)
Host Organism:
Method Details:
Experimental Method:
Resolution:
0.95 Å
R-Value Free:
0.13
R-Value Work:
0.12
R-Value Observed:
0.12
Space Group:
P 65
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Goose-type lysozyme
Gene (Uniprot):lysG
Mutations:A133V
Chain IDs:A
Chain Length:187
Number of Molecules:1
Biological Source:Salmo salar
Polymer Type:polypeptide(L)
Molecule:Inhibitor of g-type lysozyme
Gene (Uniprot):pliG
Chain IDs:B
Chain Length:111
Number of Molecules:1
Biological Source:Escherichia coli
Primary Citation
Structural basis of bacterial defense against g-type lysozyme-based innate immunity.
Cell.Mol.Life Sci. 70 1113 1122 (2013)
PMID: 23086131 DOI: 10.1007/s00018-012-1184-1

Abstact

Gram-negative bacteria can produce specific proteinaceous inhibitors to defend themselves against the lytic action of host lysozymes. So far, four different lysozyme inhibitor families have been identified. Here, we report the crystal structure of the Escherichia coli periplasmic lysozyme inhibitor of g-type lysozyme (PliG-Ec) in complex with Atlantic salmon g-type lysozyme (SalG) at a resolution of 0.95 Å, which is exceptionally high for a complex of two proteins. The structure reveals for the first time the mechanism of g-type lysozyme inhibition by the PliG family. The latter contains two specific conserved regions that are essential for its inhibitory activity. The inhibitory complex formation is based on a double 'key-lock' mechanism. The first key-lock element is formed by the insertion of two conserved PliG regions into the active site of the lysozyme. The second element is defined by a distinct pocket of PliG accommodating a lysozyme loop. Computational analysis indicates that this pocket represents a suitable site for small molecule binding, which opens an avenue for the development of novel antibacterial agents that suppress the inhibitory activity of PliG.

Legend

Protein

Chemical

Disease

Primary Citation of related structures